Related Experiment Video
Updated: Dec 17, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
A personalized cancer vaccine, when combined with the PD-L1 inhibitor atezolizumab, has shown early promise in patients with solid cancers: In a phase Ib trial, the therapy induced neoantigen-specific T-cell responses-and elicited complete or partial tumor eradication in some patients.
A personalized cancer vaccine, when combined with the PD-L1 inhibitor atezolizumab, has shown early promise in patients with solid cancers: In a phase Ib trial, the therapy induced neoantigen-specific T-cell responses-and elicited complete or partial tumor eradication in some patients.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Vaccinations

